The clinical, laboratory, and radiologic improvement due to siltuximab treatment in idiopathic multicentric Castleman’s disease
Gi-June Min, Young-Woo Jeon, Sung-Soo Park, Silvia Park, Seung-Hawn Shin, Seung-Ah Yahng, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Hee-Je Kim, Chang-Ki Min, Dong-Wook Kim, Jong-Wook Lee, Seok-Goo Cho
Korean J Intern Med. 2021;36(2):424-432. Published online 2020 Feb 24 DOI: https://doi.org/10.3904/kjim.2019.330
Citations to this article as recorded by 
Idiopathic multicentric Castleman disease: An update in diagnosis and treatment advances
Evan Lang, Frits van Rhee
Blood Reviews.2024; 64: 101161. CrossRef
Human Herpesvirus-8 Positive Multicentric Castleman’s Disease with Complete Response after Rituximab Monotherapy: A Case Report
Jun Young Kim, Seug Yun Yoon, Min-Young Lee, Namsu Lee, Jong-Ho Won, In Ho Choi, Kyoung Min Kim, Kyoung Ha Kim
Soonchunhyang Medical Science.2023; 29(1): 29. CrossRef
POEMS Syndrome: Presented as Idiopathic Multicentric Castleman Disease of Plasma Cell Variant for Eight Years and Dramatic Treatment with Siltuximab Followed by Autologous Peripheral Blood Stem Cell Transplantation
Yong-Moon Lee, Yoon Seok Choi, Jin-Man Kim
Diagnostics.2022; 12(4): 998. CrossRef
Efficacy of siltuximab in the treatment of idiopathic multicentric castleman disease, the first Polish, real-world experience with long-term observation
Beata Ostrowska, Agnieszka Szymczyk, Magdalena Olszewska-Szopa, Joanna Romejko-Jarosińska, Katarzyna Domańska-Czyż, Anna Dąbrowska-Iwanicka, Waldemar Tomczak, Sebastian Rybski, Marek Hus, Tomasz Wróbel, Jan Walewski
Leukemia & Lymphoma.2021; 62(12): 3031. CrossRef
Subaxial cervical Castleman’s disease: A rare cause of myelopathy
Abhinandan Reddy Mallepally, Amrit Gantaguru, Nandan Marathe, Tarush Rustagi, Alhad Mulkalwar, Kalidutta Das
Surgical Neurology International.2021; 12: 552. CrossRef